HCA Healthcare Today | --- | --- | |-----------------------|-------| | | | | | | | | | | HCA HCA Healthcare | | | $358.73 | | | +3.95 (+1.11%) | | | 52-Week Range $215.96 | | | ▼ | | | $361.12 | | | Dividend Yield 0.74% | | | P/E Ratio 17.88 | | | Price Target $341.12 | | | Add to Watchlist | | The nation's largest hospital operator, HCA Healthcare Inc. NYSE: HCA, surged to all-time highs following its strong Q2 2024 earnings results. The dramatic growth in acute care services has driven hospital stocks to ...

Non-accelerated filer ☐ Smaller reporting company ☐ (Mark One) HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Securities registered pursuant to Section 12(b) of the Act: Voting common stock, $.01 par value HCA New York Stock Exchange Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to ...

Relative % Price change – 4 weeks greater than 0 Current Price greater than or equal to $5 and Average 20-day Volume greater than or equal to 50,000: A minimum price of $5 is a good standard to screen low-priced stocks, while a high trading volume would imply adequate liquidity. Notably, the Zacks Consensus Estimate for Seagate Technology's fiscal 2025 earnings per share indicates 352.7% year-over-year growth. The firm has a market capitalization of $22.1 billion. STX shares have gone up 89% in a year. Inte ...

Image Source: Zacks Investment Research Furthermore, Spotify expects its monthly active users (MAU) to increase by 13 million during the third quarter to 639 million. Spotify projects its subscribers to increase by 5 million during Q3 to 251 million. Image Source: Zacks Investment Research With Tuesday's earnings lineup giving us Q2 results from magnificent seven stocks Alphabet (GOOGL) and Tesla (TSLA) among other household names, HCA Healthcare (HCA) and Spotify Technology (SPOT) are two companies that st ...

HCA Healthcare had more patients use its facilities, which helped push sales and profits for the second quarter above forecasts. Same-facility admissions, emergency room visits, and inpatient surgeries all rose for HCA Healthcare versus a year ago, although same-facility outpatient surgeries fell, the company reported. HCA Healthcare raised its full-year adjusted earnings per share and revenue guidance. HCA shares hit a record intraday high in early trading Tuesday. Company Boosts Full-Year Guidance Shares ...

Core Viewpoint - HCA Healthcare has demonstrated strong financial performance, surpassing earnings and revenue expectations, indicating a positive outlook for the company and its stock [1][2][8]. Financial Performance - HCA reported quarterly earnings of $5.50 per share, exceeding the Zacks Consensus Estimate of $4.97 per share, and showing an increase from $4.29 per share a year ago [8]. - The company achieved revenues of $17.49 billion for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 2.22% and reflecting a year-over-year increase from $15.86 billion [2]. - HCA has outperformed consensus revenue estimates four times over the last four quarters [2]. Stock Performance - HCA shares have increased approximately 20.2% since the beginning of the year, outperforming the S&P 500's gain of 16.7% [3]. - The current consensus EPS estimate for the upcoming quarter is $4.46 on revenues of $17.18 billion, and for the current fiscal year, it is $20.97 on revenues of $69.73 billion [5]. Earnings Outlook - The trend for earnings estimate revisions for HCA is favorable, contributing to a Zacks Rank 2 (Buy) for the stock, suggesting expected outperformance in the near future [12]. - The sustainability of the stock's price movement will depend on management's commentary during the earnings call [10]. Industry Context - The Medical - Hospital industry, to which HCA belongs, is currently ranked in the top 5% of over 250 Zacks industries, indicating a strong industry outlook [13]. - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [4].

Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 ● Revenues totaled $17.492 billion ● Net income attributable to HCA Healthcare, Inc. totaled $1.461 billion, or $5.53 per diluted share ● Adjusted EBITDA totaled $3.550 billion ● Cash flows from operating activities totaled $1.971 billion ● Same facility admissions increased 5.8 percent while same facility equivalent admissions increased 5.2 percent Same facility admissions increased 5 ...

Company Overview - HCA Healthcare is one of 1025 individual stocks in the Medical sector, currently holding a Zacks Rank of 2 (Buy) [2][3] - Over the past 90 days, the Zacks Consensus Estimate for HCA's full-year earnings has increased by 1.9%, indicating improved analyst sentiment [4] Performance Analysis - HCA Healthcare has achieved a year-to-date return of approximately 19%, outperforming the average gain of 6% in the Medical group [4] - In the Medical - Hospital industry, HCA Healthcare is ranked 17 and has slightly underperformed its industry, which has gained an average of 19.8% this year [6] Comparison with Peers - AnaptysBio, Inc. has outperformed the Medical sector with a year-to-date return of 57.3% and also holds a Zacks Rank of 2 (Buy) [5] - The Medical - Biomedical and Genetics industry, to which AnaptysBio belongs, is currently ranked 71 and has seen a decline of 1.1% year to date [6] Investment Consideration - Investors interested in the Medical sector may want to monitor HCA Healthcare and AnaptysBio, Inc. for their strong performance [7]

The Zacks Consensus Estimate for second-quarter earnings per share of $4.97 indicates a 15.9% increase from the prior-year figure of $4.29. The estimate increased 6 cents in the past 30 days. The consensus estimate for second-quarter revenues of $17.1 billion indicates 7.9% growth from the year-ago reported figure. HCA Healthcare beat the consensus estimate for earnings in three of the prior four quarters, missing once, with the average being 5.6%. Earnings Whispers Earnings ESP: HCA Healthcare has an Earni ...

The market expects HCA Healthcare (HCA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. Zacks Consensus Estimate Estimate Revisions Trend Earnings Whisper A positive Earnings ESP is a strong predictor of an earnings be ...